Skip to content

Clinical trials

Hemorrhagic Disorders trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Disorders Country / region: Australia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20173
20182
20191
20201
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Terminated2
Active, not recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical3
Genzyme, a Sanofi Company2
Spark Therapeutics, Inc.2
Takeda2
CTI BioPharma1
Hutchmed1
Novartis Pharmaceuticals1
Sierra Oncology LLC - a GSK company1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases14
Hemorrhagic Disorders14
Blood Coagulation Disorders10
Blood Coagulation Disorders, Inherited7
Coagulation Protein Disorders7
Genetic Diseases, Inborn7
Hemophilia A7
Blood Platelet Disorders6
Bone Marrow Diseases4
Genetic Diseases, X-Linked4

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.